Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
Expedition Money Launches “Woodland Cents,” a 53-Book Children’s Series That Teaches Kids the Money Habits, Mindset, and Values Behind a Prosperous Life — Not Just the Rules
How I Shop with Bill Bailey: ‘Could be a life-saver in an apocalypse’
Crowded nest? How parents and their adult kids can live together in peace
Here’s what happened in crypto today
A half-time scorecard for Trump-world
Netanyahu threatens ‘aggressive’ offensive after West Bank shooting
China targets 2030 for its national blockchain network buildout
Relemio Expands Its Ecosystem With Self-Custody, Multi-Chain Support, Staking and Governance
Samsung Galaxy Z Flip8 Review: The Littlest Smartphone That Could
Silver extends losses below $57.50 as support holds the spotlight
USD/CAD selling pressure keeps 1.4030 Fibonacci support in focus
Split Tunneling Is Your VPN’s Best Feature. Here’s How to Make the Most of It
Silver Outlook: XAG/USD Compresses Near $57 As Sellers Defend A Falling Trendline
Silver Outlook: XAG/USD Compresses Near $57 As Sellers Defend A Falling Trendline
Nasdaq 100 Outlook: Index Rebounds Below 30,000 As AI Earnings Meet Costly Oil
Meta Stock Outlook: Investors Weigh Huge AI Spending Ahead Of Third-Quarter Results
Apple Stock Outlook: Premium Valuation Draws Attention Ahead Of November Earnings
Bitcoin Cash Price Prediction: BCH Jumps Past Short-Term Forecast As Signals Stay Mixed
Oil Prices Extend Upside Rallies as Middle Eastern Maritime Disruptions Supercharge Global Freight Costs
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute